Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study

Objective: To analyze the effect of applying alternative diagnostic criteria for gestational diabetes mellitus (GDM) during the COVID-19 pandemic on GDM prevalence and obstetrical and perinatal outcomes, in comparison to usual diagnostic approaches. Methods: Data from women referred to GDM diagnosis...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	María Molina-Vega, Carolina Gutiérrez-Repiso, Fuensanta Lima-Rubio, María Suárez-Arana, Teresa María Linares-Pineda, Andrés Cobos Díaz, Francisco J. Tinahones, Sonsoles Morcillo, María J. Picón-César
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	gestational diabetes COVID-19 pregnancy Medicine R
Acceso en línea:	https://doaj.org/article/b890b65368c94987998c5c7e6d4f6d52
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:b890b65368c94987998c5c7e6d4f6d52
record_format	dspace
spelling	oai:doaj.org-article:b890b65368c94987998c5c7e6d4f6d522021-11-11T17:33:09ZImpact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study10.3390/jcm102149042077-0383https://doaj.org/article/b890b65368c94987998c5c7e6d4f6d522021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/4904https://doaj.org/toc/2077-0383Objective: To analyze the effect of applying alternative diagnostic criteria for gestational diabetes mellitus (GDM) during the COVID-19 pandemic on GDM prevalence and obstetrical and perinatal outcomes, in comparison to usual diagnostic approaches. Methods: Data from women referred to GDM diagnosis from 1 September to 30 November 2019 were retrospectively collected (2019-group). The same data from the same period in 2020 were prospectively collected (2020-group). In both cases, a two-step diagnostic approach was used, the first step being a screening test (1 h 50 goral glucose tolerance test, OGTT). In 2019 it was followed by a 100 gr OGTT for diagnosis. In 2020, this was replaced by a blood test for the measurement of plasma glucose and HbA1c, according to alternative GDM diagnostic criteria during the COVID-19 pandemic. Results: From 237 women in the 2019 group, 40 (16.9%) were diagnosed with GDM, while from 255 women in the 2020 group, 37 (14.5%) had GDM (<i>p</i> = 0.470). More women in the 2020 group, in comparison to the 2019 group, were nulligravid (41.9% vs. 47.2%, <i>p</i> = 0.013), had a personal history of GDM (11.4% vs. 4.6%, <i>p</i> = 0.013) and had macrosomia in previous pregnancies (10.2% vs. 2.1%, <i>p</i> = 0.001). Obstetrical and perinatal outcomes were similar when comparing women with GDM to non-GDM women in the 2019 and 2020 groups and between GDM women and non-GDM women. Conclusion: In a Spanish population, GDM prevalence during the COVID-19 pandemic using the alternative diagnostic criteria was similar to that found in 2019 using the usual diagnostic criteria. Despite women referred for GDM diagnosis during the pandemic having more GDM risk factors, obstetrical and perinatal outcomes were comparable to those observed before the pandemic.María Molina-VegaCarolina Gutiérrez-RepisoFuensanta Lima-RubioMaría Suárez-AranaTeresa María Linares-PinedaAndrés Cobos DíazFrancisco J. TinahonesSonsoles MorcilloMaría J. Picón-CésarMDPI AGarticlegestational diabetesCOVID-19pregnancyMedicineRENJournal of Clinical Medicine, Vol 10, Iss 4904, p 4904 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	gestational diabetes COVID-19 pregnancy Medicine R
spellingShingle	gestational diabetes COVID-19 pregnancy Medicine R María Molina-Vega Carolina Gutiérrez-Repiso Fuensanta Lima-Rubio María Suárez-Arana Teresa María Linares-Pineda Andrés Cobos Díaz Francisco J. Tinahones Sonsoles Morcillo María J. Picón-César Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
description	Objective: To analyze the effect of applying alternative diagnostic criteria for gestational diabetes mellitus (GDM) during the COVID-19 pandemic on GDM prevalence and obstetrical and perinatal outcomes, in comparison to usual diagnostic approaches. Methods: Data from women referred to GDM diagnosis from 1 September to 30 November 2019 were retrospectively collected (2019-group). The same data from the same period in 2020 were prospectively collected (2020-group). In both cases, a two-step diagnostic approach was used, the first step being a screening test (1 h 50 goral glucose tolerance test, OGTT). In 2019 it was followed by a 100 gr OGTT for diagnosis. In 2020, this was replaced by a blood test for the measurement of plasma glucose and HbA1c, according to alternative GDM diagnostic criteria during the COVID-19 pandemic. Results: From 237 women in the 2019 group, 40 (16.9%) were diagnosed with GDM, while from 255 women in the 2020 group, 37 (14.5%) had GDM (<i>p</i> = 0.470). More women in the 2020 group, in comparison to the 2019 group, were nulligravid (41.9% vs. 47.2%, <i>p</i> = 0.013), had a personal history of GDM (11.4% vs. 4.6%, <i>p</i> = 0.013) and had macrosomia in previous pregnancies (10.2% vs. 2.1%, <i>p</i> = 0.001). Obstetrical and perinatal outcomes were similar when comparing women with GDM to non-GDM women in the 2019 and 2020 groups and between GDM women and non-GDM women. Conclusion: In a Spanish population, GDM prevalence during the COVID-19 pandemic using the alternative diagnostic criteria was similar to that found in 2019 using the usual diagnostic criteria. Despite women referred for GDM diagnosis during the pandemic having more GDM risk factors, obstetrical and perinatal outcomes were comparable to those observed before the pandemic.
format	article
author	María Molina-Vega Carolina Gutiérrez-Repiso Fuensanta Lima-Rubio María Suárez-Arana Teresa María Linares-Pineda Andrés Cobos Díaz Francisco J. Tinahones Sonsoles Morcillo María J. Picón-César
author_facet	María Molina-Vega Carolina Gutiérrez-Repiso Fuensanta Lima-Rubio María Suárez-Arana Teresa María Linares-Pineda Andrés Cobos Díaz Francisco J. Tinahones Sonsoles Morcillo María J. Picón-César
author_sort	María Molina-Vega
title	Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_short	Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_full	Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_fullStr	Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_full_unstemmed	Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study
title_sort	impact of the gestational diabetes diagnostic criteria during the pandemic: an observational study
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/b890b65368c94987998c5c7e6d4f6d52
work_keys_str_mv	AT mariamolinavega impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy AT carolinagutierrezrepiso impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy AT fuensantalimarubio impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy AT mariasuarezarana impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy AT teresamarialinarespineda impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy AT andrescobosdiaz impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy AT franciscojtinahones impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy AT sonsolesmorcillo impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy AT mariajpiconcesar impactofthegestationaldiabetesdiagnosticcriteriaduringthepandemicanobservationalstudy
_version_	1718432085760278528

Impact of the Gestational Diabetes Diagnostic Criteria during the Pandemic: An Observational Study

Ejemplares similares